<span item_type="fundamental" item_id="cad403aa2b57e951bb03ea454ea8e822" counter_id="ST/US/USNA" env="prod"></span><span item_type="announcement" item_id="626975801417927297" env="prod"></span><p>Revenue: As of FY2027, the actual value is USD 925.26 M, missing the estimate of USD 1.001 B.</p><p>EPS: As of FY2027, the actual value is USD 0.58, missing the estimate of USD 2.29.</p><p>EBIT: As of FY2027, the actual value is USD 35.86 M.</p><p></p><h3>Overall Financial Performance</h3><ul><li><h4>Net Sales</h4><p>In 2025, consolidated net sales for USANA Health Sciences, Inc. increased by 8.3% to $925.3 million, up from $854.5 million in 2024 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>. This growth was primarily driven by $130.0 million in incremental sales from Hiya, partially offset by a decline in the core nutritional segment <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>. Unfavorable currency exchange rates decreased net sales by an estimated $3.1 million in 2025 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>.</p></li><li><h4>Net Earnings Attributable to USANA</h4><p>Net earnings attributable to USANA Health Sciences, Inc. decreased by 74.4% to $10.8 million in 2025 compared to 2024, mainly due to a lower operating margin and a substantial increase in the effective tax rate <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>.</p></li><li><h4>Gross Profit</h4><p>Consolidated gross profit decreased by 280 basis points to 78.3% of net sales in 2025, down from 81.1% in 2024 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>. This decline is largely attributed to the inclusion of Hiya, which has lower gross margins <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>.</p></li><li><h4>Earnings from Operations</h4><p>Consolidated earnings from operations were $37,432 in 2025, compared to $66,324 in 2024 and $93,071 in 2023 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>.</p></li><li><h4>Effective Tax Rate</h4><p>The effective tax rate increased to 72.4% of pre-tax earnings in 2025, up from 44.9% in 2024 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>. This was primarily due to lower U.S. earnings before taxes (including cost realignment and impairment) while foreign taxes remained relatively similar <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>.</p></li><li><h4>Cost Realignment and Impairment</h4><p>In 2025, USANA Health Sciences, Inc. incurred a one-time charge of $6,463 for cost realignment and recorded a non-cash goodwill impairment charge of $6,527 and a non-cash amortized intangible asset impairment charge of $440 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>.</p></li><li><h4>R&amp;D Expenses</h4><p>USANA Health Sciences, Inc. expended $10.7 million on product R&amp;D activities in 2025, compared to $11.6 million in 2024 and $11.4 million in 2023 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>.</p></li></ul><h3>Core Nutritional Segment</h3><ul><li><h4>Segment Revenue</h4><p>Net sales in the core nutritional business (including the ‘other’ category) were $793.3 million in 2025, representing a 6.9% decrease from 2024 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>. On a constant currency basis, net sales declined by 6.6% <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>.</p></li><li><h4>Active Customers</h4><p>As of January 3, 2026, the core nutritional business had approximately 387,000 active Customers worldwide, a 14.8% decrease from 454,000 in December 2024 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>. This decrease in active Customers was partially offset by a 4.4% increase in average spend per customer <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>.</p></li><li><h4>Brand Partner Incentives</h4><p>Brand Partner incentives decreased by 30 basis points to 42.4% of segment net sales in 2025, compared with 42.7% in the prior year, mainly due to the ‘other’ category not incurring such expenses <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>. Excluding the ‘other’ category, Brand Partner incentives expense increased by 5 basis points to 43.3% of core nutritional net sales <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>.</p></li><li><h4>Selling, General and Administrative Expenses</h4><p>For the core nutritional segment, these expenses increased by 150 basis points relative to net segment sales but decreased by $6.9 million in absolute terms compared to the prior year <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>.</p></li><li><h4>Geographic Performance (YoY local currency net sales, active customers, average spend)</h4><ul><li><strong>Asia Pacific</strong>: Net sales declined 8.2% (-8.0% constant currency) <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>. Active Customers declined 10.8%, with average spend per customer up 3.2% <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>.<ul><li><strong>China</strong>: Local currency net sales -7.4%, Active Customers -10.9%, Average spend per active Customer 3.8% <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>.</li><li><strong>South Korea</strong>: Local currency net sales -5.8%, Active Customers -6.8%, Average spend per active Customer 1.7% <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>.</li><li><strong>Malaysia</strong>: Local currency net sales -16.7%, Active Customers -17.3%, Average spend per active Customer 1.2% <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>.</li><li><strong>Australia</strong>: Local currency net sales -12.4%, Active Customers -9.1%, Average spend per active Customer -3.8% <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>.</li></ul></li><li><strong>Americas and Europe</strong>: Net sales declined 8.9% (-7.8% constant currency) <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>. Active Customers declined 14.4%, with average spend per customer up 8.6% <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>.<ul><li><strong>United States</strong>: Local currency net sales -7.8%, Active Customers -14.9%, Average spend per active Customer 8.3% <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>.</li><li><strong>Canada</strong>: Local currency net sales -4.3%, Active Customers -11.1%, Average spend per active Customer 7.6% <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>.</li><li><strong>Mexico</strong>: Local currency net sales -8.3%, Active Customers -16.9%, Average spend per active Customer 10.1% <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>.</li></ul></li></ul></li></ul><h3>Hiya Direct-to-Consumer Segment</h3><ul><li><h4>Segment Revenue</h4><p>Hiya’s net sales were $131,971 in 2025, a significant increase from $1,970 in 2024, as 2025 represented a full year of operations post-acquisition <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>.</p></li><li><h4>Active Monthly Subscribers</h4><p>As of January 3, 2026, Hiya had approximately 181,700 active Monthly Subscribers <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>.</p></li><li><h4>Gross Profit</h4><p>Hiya carries lower gross margins relative to the core nutritional segment <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>.</p></li><li><h4>Selling, General and Administrative Expenses</h4><p>This segment has a higher mix of selling, general and administrative expenses, mainly concentrated in advertising spend, payroll, other professional services, and amortization of acquired intangible assets <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>.</p></li></ul><h3>Other Category (Rise and Oola)</h3><ul><li>#### Segment RevenueNet sales for the ‘Other’ category were $17,834 in 2025, a 164.4% increase from $6,744 in 2024 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>.</li></ul><h3>Cash Flow</h3><ul><li><h4>Cash and Cash Equivalents</h4><p>Cash and cash equivalents decreased to $158.4 million at January 3, 2026, from $181.8 million at December 28, 2024 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>.</p></li><li><h4>Operating Cash Flow</h4><p>Net cash flow provided by operating activities totaled $22.3 million in 2025, compared to $61.0 million in 2024 and $70.6 million in 2023 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>.</p></li><li><h4>Investing Activities</h4><p>Cash used in investing activities was $10.1 million in 2025, primarily for property and equipment purchases <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>.</p></li><li><h4>Financing Activities</h4><p>Cash used in financing activities was $40.6 million in 2025, including $27.5 million for common stock repurchases <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>.</p></li><li><h4>Restricted Cash</h4><p>Restricted cash included in other assets was $2,860 as of January 3, 2026, and $2,740 as of December 28, 2024 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>.</p></li></ul><h3>Outlook / Guidance</h3><p>USANA Health Sciences, Inc. plans to continue investing in R&amp;D to advance expertise in cellular nutrition and overall health and wellness, with further investment into early-stage research and scientific innovation in 2026 <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>. The company also intends to accelerate technology initiatives to modernize core systems, improve customer experience, and create future cost efficiencies across its IT infrastructure <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>. Additionally, 优莎娜 expects to continue pursuing acquisition opportunities in the health and wellness space that strengthen, diversify, and grow its worldwide business <span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/896264/000089626426000021/usna-20260103.htm"></span>.</p>

USANA Health Sciences | 10-K: FY2027 Revenue Misses Estimate at USD 925.26 M